Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 12:00 source : Www.renalytixai.com save search
New Published Real-World Evidence Shows KidneyIntelX™ Utility
Published: 2023-04-19 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: 2.05%
H: 0.4%
C: 0.4%
Renalytix Reports Full Year Fiscal 2022 Results
Published: 2022-10-31 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -1.8%
H: 36.59%
C: 18.9%
year results
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31
Published: 2022-10-24 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -4.89%
H: 4.66%
C: -0.93%
report year financial
Renalytix Announces Change to Board of Directors
Published: 2022-09-20 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: 0.0%
H: 4.03%
C: -0.67%
Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-08 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -2.94%
H: 6.06%
C: 2.42%
global conference
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians
Published: 2022-08-08 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: 1.9%
H: 2.06%
C: -2.99%
care results
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
Published: 2022-06-30 (Crawled : 12:00) - renalytixai.com
DVA | News | $132.52 3.68% -0.12% 540K
|
Health Services
|
| O: -0.98%
H: 0.26%
C: -0.87%
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -24.43%
H: 0.0%
C: -18.33%
TECH | $62.8 1.1% 1.07% 830K
|
Health Technology
|
| O: 0.81%
H: 2.09%
C: 0.65%
year
1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients
Published: 2022-06-10 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -4.76%
H: 0.0%
C: 0.0%
care disease kidney benefits diabetic
Renalytix to Present at 42nd Annual William Blair Growth Stock Conference
Published: 2022-06-08 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -0.72%
H: 15.38%
C: 12.98%
conference growth
KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort
Published: 2022-06-06 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -2.65%
H: 0.0%
C: -9.98%
risk disease heart kidney international diabetic
Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions®
Published: 2022-06-02 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: 5.54%
H: 13.37%
C: 9.31%
sessions diabetes
Renalytix plc successful completion of $30.0 million financing package
Published: 2022-04-08 (Crawled : 12:00) - renalytixai.com
RNLX | $0.7465 -6.92% -13.78% 200K
|
Technology Services
|
| O: -1.11%
H: 2.09%
C: -0.32%
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
PROK | $2.72 33.33% 24.58% 2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.